awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37725994-1B67DEB8-027D-4FA2-B62B-F98DD46E6E01
Q37725994-1B67DEB8-027D-4FA2-B62B-F98DD46E6E01
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37725994-1B67DEB8-027D-4FA2-B62B-F98DD46E6E01
Novel inhibitors in development for hepatocellular carcinoma.
P2860
Q37725994-1B67DEB8-027D-4FA2-B62B-F98DD46E6E01
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37725994-1B67DEB8-027D-4FA2-B62B-F98DD46E6E01
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da5a33d1a847e9be54181acb3223018474fc1393
P2860
Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.